PRVA
Privia Health Group, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 26 ▲ Privia Health reported strong full-year 2025 results with revenue of…
- Mar 6 ▼ Two executive insiders at Privia Health Group (PRVA), the CFO and Ge…
- Mar 9 ▼ Privia Health CFO David Mountcastle and CEO Parth Mehrotra collectiv…
- Mar 9 ▼ Privia Health executives, including CEO Parth Mehrotra and CFO David…
- May 1 to May 12 ▼ 4 days of insider sells: $3.5M by 3 insiders, avg $22.99
- May 7 Privia Health reported Q1 2026 revenue of $603.8M (+25.8% YoY) and G…
- May 27 Contract: Privia Health Enters New Jersey
- Jun 26 to Jul 9 ▼ 8 days of insider sells: $12.2M by 2 insiders, avg $26.32
- Aug 14 ▼ Short interest jumps 37.9% to 5.29M
- Nov 2 M&A: Privia Health Expands VBC Footprint with Acquisition of Am…
- Nov 5 Privia Health reported Q3 2026 revenue of $657.0M (+13.2% YoY) and G…
- Nov 5 ▲ Earnings: PRVA Q3 2026 Earnings: EPS $0.1 (+3.7% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders sold $15.7M.
- InstitutionsBULLISH
Q3 2026: 26 added (2 new), 15 trimmed or exited. Largest new: Hrt Financial $10.5M.
- AnalystsBULLISH
22 of 24 rate it Buy or better. Median target $31.00 (+23%).
- Short sellersCOVERING
Short interest −22.2% to 3.90M shares. 4.5 days to cover, ≈3.0% of shares.
- TrendUPTREND
18% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | TRIM | $134.5M |
| LOOMIS SAYLES & CO L P | DOUBLED | $40.1M |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | ADD | $34.2M |
| FRANKLIN TEMPLETON INC | TRIM | $20.2M |
| HRT FINANCIAL LP | NEW | $10.5M |
| FIRST TRUST ADVISORS LP | ADD | $8.6M |
| LOS ANGELES CAPITAL MANAGEMENT LLC | DOUBLED | $7.9M |
| Squarepoint Ops LLC | ADD | $7.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
24 analystsPrice is inside the target range. Median implies +23%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 6, 2026 | Canaccord Genuity MAINTAIN | Buy |
| Nov 6, 2026 | Piper Sandler MAINTAIN | Overweight |
| May 26, 2026 | Barclays MAINTAIN | Equal-Weight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Ernest Opella Finley Director Sep 1, 2026 | AWARD | 6,350 sh |
Mountcastle David EVP & Chief Financial Officer Jul 9, 2026 | SELL | $588.7K |
Mountcastle David EVP & Chief Financial Officer Jul 7, 2026 | SELL | $16.5K |
Morris Matthew Shawn Director Jul 6, 2026 | EXERCISE | $107.4K |
Morris Matthew Shawn Director Jul 6, 2026 | SELL | $1.5M |
Mountcastle David EVP & Chief Financial Officer Jul 2, 2026 | SELL | $680.2K |
Morris Matthew Shawn Director Jul 2, 2026 | EXERCISE | $118.1K |
Morris Matthew Shawn Director Jul 2, 2026 | SELL | $1.6M |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
18 filings · 2 press releases · 1 bullish · 4 bearish · 2 mixed · 11 neutral- MIXED 8-KNov 5, 2026
Privia Health reported Q3 2026 revenue of $657.0M (+13.2% YoY) and GAAP diluted EPS of $0.10…
The EPS miss is stark but the raised guidance and acquisition signal operational confidence. Activist presence adds pressure for margin improvement and capital allocation. Watch the Q3 10-Q filing…
- BEARISH PRESS-RELEASENov 5, 2026
Privia Health reported Q3 2026 adjusted EPS of $0.21, missing the $0.24 consensus by 12.5%, while…
The EPS miss on the Street basis is the primary negative, but the revenue beat and raised guidance provide a counterbalance. Monitor the Q4 2026 earnings call for updates on the American Choice…
- NEUTRAL PRESS RELEASENov 2, 2026
Privia Health acquired American Choice Healthcare MSSP (ACH) from Cano Health for $36M in cash…
The $36M cash deal is small relative to Privia's $2.8B market cap and adds modest scale to its value-based care platform. Monitor the 2027 contribution to Attributed Lives and Adjusted EBITDA as the…
- NEUTRAL SC 13GOct 30, 2026
Vanguard Capital Management LLC filed a new Schedule 13G disclosing beneficial ownership of…
Monitor for any future amendments that show a material increase or decrease in Vanguard's position, which could signal a change in passive allocation. No activist intent is indicated.
All PRVA filing & press-release reports (20)
- 8-K reportNov 5, 2026
- PRESS-RELEASE reportNov 5, 2026
- PRESS-RELEASE reportNov 2, 2026
- SC 13G reportOct 30, 2026
- SC 13G/A reportOct 7, 2026
- CLUSTER reportJul 13, 2026
- CLUSTER reportJul 9, 2026
- CLUSTER reportJul 7, 2026
- PRESS-RELEASE reportJul 7, 2026
- CLUSTER reportJul 2, 2026
- PRESS-RELEASE reportMay 27, 2026
- 3 reportMay 22, 2026
- CLUSTER reportMay 4, 2026
- 8-K reportMay 7, 2026
- CLUSTER reportMay 1, 2026
- DEFA14A reportApr 2, 2026
- CLUSTER reportMar 9, 2026
- CLUSTER reportMar 9, 2026
- CLUSTER reportMar 6, 2026
- 8-K reportFeb 26, 2026